In vitro and in vivo studies to assess the suitability of anti-tuberculous drugs for use in intermittent chemotherapy regimens.
D000818:Animals; D000995:Antitubercular Agents / Q000008:administration & dosage*; D003523:Cycloserine / Q000008:administration & dosage; D004977:Ethambutol / Q000008:administration & dosage; D005000:Ethionamide / Q000008:administration & dosage; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007538:Isoniazid / Q000008:administration & dosage; D008722:Methods; D010670:Phenylthiourea / Q000008:administration & dosage / Q000031:analogs & derivatives; D011718:Pyrazinamide / Q000008:administration & dosage; D013307:Streptomycin / Q000008:administration & dosage; D013828:Thioacetazone / Q000008:administration & dosage; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D010670:Phenylthiourea; D004977:Ethambutol; D003523:Cycloserine; D013828:Thioacetazone; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin